Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Considerations for use of Taq Polymerase in Molecular Diagnostic Assays

Part # PS264

Abstract

Rod Pennington, Terri McDonnell, Jenn Mook, Karen Reece, Letta Steffen, Nadine Nassif, Katharine Hoffmann, Doug Storts
Promega Corporation, Madison, WI

Many molecular diagnostic assays utilize PCR technology to understand and diagnose disease. Taq DNA Polymerase(1) is a commonly used engine to drive PCR. The quality, performance and format of the Taq DNA polymerase enzyme influence the design and performance of a PCR-based molecular diagnostic assay. The ability of the enzyme to perform in multiple PCR applications and multiple Taq DNA polymerase product formats contribute flexibility to the design of the molecular diagnostic assay. Manufacture of the enzyme under GMP yields lot-to-lot consistent enzyme with minimal product contaminants (such as nucleases and nucleic acids) that support a consistently performing molecular diagnostic assay.

(1)The products described are general purpose reagents intended for general laboratory use. These products may be used as components of molecular diagnostic assays where applicable country laws allow.



Printed in USA.